EMEA-000433-PIP01-08
Key facts
Active substance |
Dirucotide acetate
|
Therapeutic area |
Neurology
|
Decision number |
P/43/2009
|
PIP number |
EMEA-000433-PIP01-08
|
Pharmaceutical form(s) |
Powder for solution for injection
|
Condition(s) / indication(s) |
Multiple Sclerosis
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|